SGXP Sgx Pharmaceuticals (MM)

SAN DIEGO, March 20 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (NASDAQ:SGXP) will be presenting at the Future Leaders in the Biotech Industry Conference hosted by BioCentury and Thomson on Thursday, March 27, 2008 at 9:00 AM Eastern Daylight Time. Mike Grey, president and chief executive officer of SGX Pharmaceuticals, will provide an overview of the Company's oncology pipeline. The conference is being held at the Millennium Broadway Hotel and Conference Center in New York City. A live webcast of the presentation will be available under the investor relations section of the Company's website at http://www.sgxpharma.com/. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. About SGX Pharmaceuticals SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as SGX523, a MET kinase inhibitor currently in Phase 1 clinical studies, next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis and a portfolio of inhibitors of various oncology targets. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com/ and in the Company's various filings with the Securities and Exchange Commission. DATASOURCE: SGX Pharmaceuticals, Inc. CONTACT: Bonnie Feldman, Sr. Director, Investor Relations, of SGX Pharmaceuticals, Inc., +1-858-344-8860 Web site: http://www.sgxpharma.com/

Copyright